Tariffs and Life Sciences Supply Chain

When supply chains stall and regulatory winds shift, do your operations bend - or break?

We help life sciences companies gain a competitive advantage amid volatility. Our consulting expertise enables companies to develop best-of-breed facility qualification, operational resilience, and sourcing strategies. Our solutions are tailored, targeted, and practical - especially in situations that demand speed, precision, and regulatory compliance.

The global pipeline is fragile, covering everything from saline drips to GLP-1 therapies. Tariff shifts, regulatory ambiguity, and sourcing bottlenecks can slow operations down, but standing still is not a strategy.

The disruptions haven’t slowed, but how companies respond is starting to change. We’re seeing less reliance on rigid playbooks and more openness to practical, sometimes unconventional solutions. Speed matters, but so does regulatory confidence. Teams want options they can defend, not just move on. That’s the space we operate in: helping organisations act decisively without overextending their risk tolerance.

Operational readiness: Build facilities that launch faster

Facility qualification and commissioning

We lead qualification efforts that meet global expectations, reducing startup delays and regulatory friction.

Production qualification

We validate production processes end-to-end for drugs, biologics, and devices - so you can scale with confidence.

Sourcing resilience: Rethink the way you source

Supply chain engineering

Redesign global sourcing models to resist tariffs, IP restrictions, and compliance traps.

LATAM market entry

Navigate registration and facility readiness to unlock new sourcing geographies.

Compounding and direct alternatives

We help you source around the bottlenecks - with compliant, creative workarounds.

Regulatory access: Stay aligned across borders

Facility registration and re-registration

Maintain uninterrupted approvals with full-service global registration support.

Post-market service programmes

For medical devices, we build compliant US repair/service models to meet FDA and customer needs.

Tariff intelligence and sourcing strategy

Get ahead of policy changes with real-time insights and proactive sourcing planning.

For many life sciences companies, operational strategy used to mean long-term planning, stable sourcing, linear launches, and predictable approvals. That model doesn’t hold up anymore. Teams now have to build flexibility into the core of their processes, not just as a backup plan. Whether it’s navigating tariffs, rethinking registration timelines, or adjusting sourcing routes on short notice, the challenge isn’t just technical - it’s organisational. We work with companies to adapt faster, without losing sight of compliance or long-term goals.

• End-to-end expertise: From facility buildout to sourcing resilience
• Global reach, local insight: We operate in 50+ markets with regional knowledge
• Deep regulatory fluency: Across FDA, EU GMP, ANVISA, and more
• Confidential, tailored support: Hands-on, high impact, always focused on your outcomes